CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ABBV

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Sep '27
ABBVPhase 3

Ibrutinib Phase 3 Est. Readout (CLL17)

Ibrutinib
Sep 2027~
CT.gov
00%
Q3 '27
ABBVPhase 2

Ibrutinib Phase 2 Est. Readout

Ibrutinib
Q3 2027~Q
CT.gov
00%
Competitive Landscape

0 competitors in Mantle Cell Lymphoma (MCL)

View Full Landscape
Drug Information

Target Indication

Mantle Cell Lymphoma (MCL)

Clinical Trial

NCT04477486

Last updated: 10/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.